These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 9847974)
21. [Use of plethysmography for the evaluation of peripheral blood vessels with particular reference to Raynaud's disease and conditions preceding scleroderma]. Stroińska W Przegl Dermatol; 1967; 54(4):463-9. PubMed ID: 6052346 [No Abstract] [Full Text] [Related]
22. [How to recognize scleroderma]. Francès C; Ayoub N; Barete S Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864 [TBL] [Abstract][Full Text] [Related]
23. [Scleroderma and Raynaud's phenomenon: current pathogenetic interpretations and clinico-therapeutic trends]. Zelli GP; Cannata P Ann Ital Chir; 1981; 53(3):337-43. PubMed ID: 7337317 [No Abstract] [Full Text] [Related]
24. Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management. Racz H; Mehta S J Rheumatol; 2006 Sep; 33(9):1723-5. PubMed ID: 16960934 [No Abstract] [Full Text] [Related]
25. Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis. Yamane K Intern Med; 1994 Oct; 33(10):579-82. PubMed ID: 7827371 [TBL] [Abstract][Full Text] [Related]
26. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment. Kumar N; Griffiths B; Allen J J Rheumatol; 2006 Sep; 33(9):1918-9. PubMed ID: 16960964 [No Abstract] [Full Text] [Related]
27. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy? Sasahara AA J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719 [No Abstract] [Full Text] [Related]